Product
Diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b vaccine
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Phase III, Single Center, Randomized, Blind, and Positive Control Clinical Trial to Evaluate the Immunogenicity and Safety of Diphtheria, Tetanus and Acellular Pertussis (Component) Combined Vaccine (Adsorbed) in 3-month-old InfantsStatus: Recruiting, Estimated PCD: 2025-05-25